Glipizide
- Product NDC
- 50090-6473
- 11-digit product format
- 500906473
- Labeler code
- 50090
- Product ID
- 50090-6473_d051028d-22b3-4b80-a593-3bdb08fa2914
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA074223
- Marketing category
- ANDA
- Marketing start
- 1995-02-27
- Substance
- GLIPIZIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glipizide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLIPIZIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | X7WDT95N5C |
| Rxcui | 310490 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-6473 | GLIPIZIDE TABLET [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, 5 package rows | 20250403_b31ab6dd-0277-43ee-a054-f20c462f0c56.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-6473-0 | 50090647300 | 30 TABLET in 1 BOTTLE (50090-6473-0) | 30 tablet | 2023-05-11 | No | No | Current |
| 50090-6473-1 | 50090647301 | 60 TABLET in 1 BOTTLE (50090-6473-1) | 60 tablet | 2023-05-11 | No | No | Current |
| 50090-6473-2 | 50090647302 | 100 TABLET in 1 BOTTLE (50090-6473-2) | 100 tablet | 2023-05-11 | No | No | Current |
| 50090-6473-3 | 50090647303 | 90 TABLET in 1 BOTTLE (50090-6473-3) | 90 tablet | 2023-05-11 | No | No | Current |
| 50090-6473-4 | 50090647304 | 180 TABLET in 1 BOTTLE (50090-6473-4) | 180 tablet | 2023-05-11 | No | No | Current |